A Study to Evaluate Mirabegron in Pediatric Participants From 5 to Less Than 18 Years of Age With Overactive Bladder (OAB)

Clinical trial NCT04641975 · TERMINATED

Trial details

NCT number: NCT04641975
Sponsor: Astellas Pharma Global Development, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Overactive Bladder (OAB)Pharmacokinetics of Mirabegron

Start date: 2021-03-15
Primary completion: 2023-07-07
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.